53014-594 : 8 Hr Metadate 20 mg Extended Release Tablet

NDC:	53014-594
Labeler:	Ucb Manufacturing, Inc.
Product Type:	Human Prescription Drug
Drug Name:	Metadate ER
Dosage Form:	Oral Tablet, Extended Release
Application #:	ANDA089601
Rev. Date:	Jun 1, 1988
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:

Markings:	562;MD
Shapes:	Round
Colors:	White
Size (mm):	8
Segments: *	1
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

• 53014-594-07: 100 TABLET, EXTENDED RELEASE IN 1 BOTTLE (53014‑594‑07)

Active Ingredients:

• Methylphenidate Hydrochloride

Inactive Ingredients:

• Cetyl Alcohol
• Ethylcelluloses
• Anhydrous Lactose
• Magnesium Stearate

Pharmaceutical Classes:

• Central Nervous System Stimulant [EPC]
• Central Nervous System Stimulation [PE]

Related Products:

Based on records with the same trade name.

• 0527-2562 Metadate ER 20 mg Oral Tablet, Extended Release by Lannett Company, Inc.
• 65580-594 Metadate ER 20 mg Oral Tablet, Extended Release by Upstate Pharma, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 53014-584Next: 53014-726 >

Related Discussions: